Cancer Vaccine

For the first time, a large population-wide study of young women found no new cases of cervical cancer among those who had received a vaccine against human papillomavirus (HPV).

Roswell Park is opening a clinical trial to study the CIMAvax-EGF® vaccine, a cancer treatment that was developed in Cuba. It will be used to treat lung cancer, the most common cause of cancer death worldwide. This vaccine trial is innovative in three significant ways.